文献速递眼底病与葡萄膜炎青光眼

玻璃体切除术后的高眼压与青光眼:系统综述与荟萃分析

Ocular Hypertension and Glaucoma After Pars Plana Vitrectomy: A Systematic Review and Meta-Analysis.
PubMed 文献 · Ophthalmology · 2025-10-08

该系统综述与荟萃分析纳入41项观察性研究(54006例患者、54021只眼),评估玻璃体切除术(PPV)后高眼压(OHT)和青光眼风险,并关注晶状体状态的影响。PPV后OHT合并绝对风险为5.6%(95%CI 3.1-9.9),青光眼为3.9%(95%CI 2.0-7.2)。人工晶状体眼较有晶状体眼OHT风险约高3倍(OR 3.2),青光眼风险约高12倍(OR 11.8)。

要点

  • PPV后OHT合并绝对风险5.6%,青光眼3.9%,证据确定性低。
  • 人工晶状体眼较有晶状体眼OHT的OR为3.2(95%CI 1.4-9.9),NNTH为8。
  • 人工晶状体眼较有晶状体眼青光眼OR为11.8(95%CI 4.2-33.6),NNTH为10。

核心结论

  • PPV与临床上有意义的高眼压和青光眼风险相关,尤其在人工晶状体眼中。
  • 尽管存在非随机数据与异质性等局限,这些发现突出晶状体状态是PPV后风险的关键修饰因素,并支持个体化手术规划和术后监测。

研究设计与样本

  • 研究方案前瞻性注册于国际系统综述前瞻性注册平台(CRD42024541683),数据报告遵循系统综述与荟萃分析优先报告条目指南。
  • 纳入报告成人PPV后OHT或青光眼的随机或非随机对照研究,最后检索Ovid MEDLINE、Ovid EMBASE和Web of Science的日期为2024年5月25日。
  • 两名评价者独立筛选、提取数据并进行非随机干预研究偏倚风险(ROBINS-I)评估,采用广义线性混合效应模型进行荟萃分析,并评估发表偏倚与异质性。
  • 共纳入41项观察性研究(54006例患者,54021只眼),采用GRADE评估证据确定性,并按Cochrane手册推荐的标准公式计算危害需治疗人数(NNTH)。

主要发现

  • PPV后OHT的合并绝对风险为5.6%(95%CI 3.1-9.9;I²=94.6%;低确定性)。
  • PPV后青光眼的合并绝对风险为3.9%(95%CI 2.0-7.2;I²=94.4%;低确定性)。
  • 人工晶状体眼较有晶状体眼OHT的OR为3.2(95%CI 1.4-9.9;I²=75.1%;NNTH为8;极低确定性)。
  • 人工晶状体眼较有晶状体眼青光眼的OR为11.8(95%CI 4.2-33.6;I²=0%;NNTH为10;中等确定性)。

局限性

  • 原文指出局限包括非随机数据。
  • 原文指出局限包括异质性。
  • OHT合并绝对风险的证据确定性为低(I²=94.6%)。
  • 青光眼合并绝对风险的证据确定性为低(I²=94.4%)。
  • 人工晶状体眼较有晶状体眼OHT的OR证据确定性为极低(I²=75.1%)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

TOPIC: To evaluate whether pars plana vitrectomy (PPV) increases the risk of ocular hypertension (OHT) and glaucoma, with particular focus on lens status as a risk modifier. CLINICAL RELEVANCE: Ocular hypertension and glaucoma are major complications that can threaten vision and require lifelong management. Although PPV is a standard treatment for vitreoretinal disease, concerns exist about its long-term effects on intraocular pressure and glaucoma, particularly in pseudophakic eyes, where the natural lens barrier is absent. No clear quantitative synthesis currently informs risk stratification in this context. METHODS: The protocol for this systematic review and meta-analysis was prospectively registered in International Prospective Register of Systematic Reviews (CRD42024541683), and data reporting followed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. Eligible studies were randomized or nonrandomized comparative studies reporting OHT or glaucoma after PPV in adults. We last searched Ovid MEDLINE, Ovid EMBASE, and Web of Science on May 25, 2024. Two reviewers independently conducted screening, data extraction, and Risk of Bias in Non-randomized Studies-of Interventions (ROBINS-I) risk of bias assessment. Meta-analyses were performed using generalized linear mixed-effects models. Publication bias and heterogeneity were assessed. The ROBINS-I tool was used to assess the risk of bias in nonrandomized studies, and the certainty of evidence was evaluated using Grading of Recommendations, Assessment, Development, and Evaluation. Numbers needed to treat for harm (NNTH) were calculated using standard formulas as recommended in the Cochrane Handbook to enhance the clinical interpretability of the results. RESULTS: Forty-one observational studies (54 006 patients, 54 021 eyes) were included. The pooled absolute risk was 5.6% (95% confidence interval [CI]: 3.1-9.9; I2 = 94.6%; low certainty) for post-PPV OHT, and 3.9% (95% CI: 2.0-7.2; I2 = 94.4%; low certainty). Pseudophakic eyes had a threefold higher odds of OHT compared to phakic eyes (odds ratio [OR], 3.2; 95% CI: 1.4-9.9; I2 = 75.1%; NNTH, 8; very low certainty) and nearly 12-fold higher odds of glaucoma (OR, 11.8; 95% CI: 4.2-33.6; I2 = 0%; NNTH, 10; moderate certainty). CONCLUSION: Pars plana vitrectomy is associated with clinically meaningful risk of OHT and glaucoma, especially in pseudophakic eyes. Despite limitations from nonrandomized data and heterogeneity, these findings highlight lens status as a key modifier of post-PPV risk and support tailored surgical planning and postoperative monitoring. FINANCIAL DISCLOSURES: The author(s) have no proprietary or commercial interest in any materials discussed in this article.

来源:Ophthalmology,查看原文。版权归原作者所有。

引用

  1. Gallo Afflitto G, Fabozzi L, Palmieri F, et al. Ocular Hypertension and Glaucoma After Pars Plana Vitrectomy: A Systematic Review and Meta-Analysis. Ophthalmology. 2025. PMID: 41072737. doi:10.1016/j.ophtha.2025.09.027

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。